QualityStocksNewsBreaks – Numinus Wellness Inc. (TSX.V: NUMI) Advances MAPS-Sponsored MDMA-Assisted Therapy for PTSD Trials
Numinus Wellness (TSX.V: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, recently announced that it has secured two new Canadian psychedelic clinics to host the Canadian sites of the MAPS Public Benefit Corporation (MAPS PBC) study “A multi-site open-label extension study of MDMA-assisted psychotherapy for PTSD (MAPPUSX).” Per the release, the two new clinics are fully compliant with Health Canada regulations and ready to provide MDMA-assisted therapy as part of the trial. The Montreal and Vancouver sites, hosted by Numinus, will continue to advance the study of the safety and efficacy of MDMA in treating severe PTSD, under…
